Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival
- PMID: 10030735
- DOI: 10.1007/BF02482235
Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival
Abstract
The correlations of nm23-H1 expression in primary cancer lesions with the already confirmed 14 prognostic variables and survival were examined in 52 advanced colorectal cancer patients, because the clinical roles of nm23-H1 expression in the cancer lesions remain controversial. An immunohistochemical expression of nm23-H1 was found in 23 lesions (positive group) but not found in 29 lesions (negative group). No significant difference between the positive and negative groups was found according to 12 clinicopathological variables including vascular invasion, lymph node and liver metastases, and histological stage. The carcinoembryonic antigen levels (21.5+/-33.4 ng/ml) of the draining venous blood and argyrophilic nucleolar organizer regions score (3.35+/-1.36 per nucleus) of the cancer cells in the positive group were not significantly diffeent from those (34.1+/-102.9 ng/ml and 3.32+/-1.00 per nucleus, respectively) in the negative group. In addition, no significant difference was found in the survival curves or the 5-year survival rates of the positive and negative groups. From these results, it may be concluded that the nm23-H1 expression was not associated with the aforementioned prognostic variables and the prognosis of advanced colorectal cancer patients.
Similar articles
-
Nm23 gene product expression in invasive breast cancer--immunohistochemical analysis and clinicopathological correlation.Acta Oncol. 2002;41(4):355-61. doi: 10.1080/028418602760169406. Acta Oncol. 2002. PMID: 12234027
-
The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.Am J Gastroenterol. 1997 Jul;92(7):1182-6. Am J Gastroenterol. 1997. PMID: 9219795
-
High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases.Br J Cancer. 1994 Nov;70(5):1025-30. doi: 10.1038/bjc.1994.442. Br J Cancer. 1994. PMID: 7947079 Free PMC article.
-
Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia.Leuk Lymphoma. 1998 Dec;32(1-2):19-28. doi: 10.3109/10428199809059243. Leuk Lymphoma. 1998. PMID: 10036998 Review.
-
Relations of nm23 expression to clinicopathologic variables and proliferative activity of gastric cancer lesions.Cancer Detect Prev. 1998;22(3):246-50. doi: 10.1046/j.1525-1500.1998.0oa27.x. Cancer Detect Prev. 1998. PMID: 9618047 Review.
Cited by
-
Reduced NM23 Protein Level Correlates With Worse Clinicopathologic Features in Colorectal Cancers: A Meta-Analysis of Pooled Data.Medicine (Baltimore). 2016 Jan;95(4):e2589. doi: 10.1097/MD.0000000000002589. Medicine (Baltimore). 2016. PMID: 26825905 Free PMC article. Review.
-
Is there a genetic signature for liver metastasis in colorectal cancer?World J Gastroenterol. 2007 Nov 28;13(44):5832-44. doi: 10.3748/wjg.v13.i44.5832. World J Gastroenterol. 2007. PMID: 17990349 Free PMC article. Review.
-
Prognostic Value of NME1 (NM23-H1) in Patients with Digestive System Neoplasms: A Systematic Review and Meta-Analysis.PLoS One. 2016 Aug 12;11(8):e0160547. doi: 10.1371/journal.pone.0160547. eCollection 2016. PLoS One. 2016. PMID: 27518571 Free PMC article.
-
NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.Lab Invest. 2018 Feb;98(2):219-227. doi: 10.1038/labinvest.2017.105. Epub 2017 Oct 9. Lab Invest. 2018. PMID: 28991262
-
The role of NM23 in patients with colorectal cancer: A systematic review and meta-analysis.J Huazhong Univ Sci Technolog Med Sci. 2017 Feb;37(1):1-10. doi: 10.1007/s11596-017-1686-z. Epub 2017 Feb 22. J Huazhong Univ Sci Technolog Med Sci. 2017. PMID: 28224416
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials